Word: eschenbach
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Baxter, the FDA devised a test that now identifies OSCS in heparin. The FDA will deploy eight full-time staffers in China, including four inspectors and a senior technical expert in foods, medicines and medical devices. And working with its counterpart agency in Beijing--which FDA commissioner Andrew van Eschenbach acknowledges is primarily responsible for drug safety there--the FDA will now be able to do "more timely" inspections in China. In 2008 the FDA did all of 30 inspections in China...
...page review that deemed the FDA's conclusions flawed - and to hear comments from the public about whether the compound should be banned from food and beverage containers. The board will now forward the review along with the FDA's original safety assessment to FDA chief Dr. Andrew von Eschenbach. The FDA has until February 2009, when the Science Board next meets, to respond...
...Eschenbach to decide how to proceed. He may start from scratch and commission another report that includes the most recent findings on BPA; he may reject the panel's review and adhere to the FDA's original conclusion that BPA is harmless at current exposure levels; or he may ban the chemical from baby products, as the Canadian government did in April. Or he may draw no further conclusions about BPA until additional studies can be commissioned and completed to answer some unresolved questions...
...Republican and Democratic lawmakers alike piled the bad news on FDA Commissioner Dr. Andrew von Eschenbach-asserting that a plan to close 7 of the FDA's 13 labs would further weaken an already impotent agency that has very little power to preemptively halt contaminated food from entering the country...
...younger for the kind of studies the FDA wanted, since young teens make up such a small segment of the population needing emergency contraception.) The decision to limit over-the-counter sales to women 18 and up was a compromise reached by the FDA and announced by von Eschenbach - and it's a decision that Barr still intends to challenge. "We'd like to continue to do clinical work now to address the younger patients," says spokeswoman Carol Cox. In the meantime, Cox says, Barr plans to have its brand-new single-purpose prescription and over-the-counter packaging ready...